76 related articles for article (PubMed ID: 15501433)
1. Induction of c-fos messenger RNA by 3-(N-phenylamino)-1,2-propanediol esters, compounds related to Toxic Oil Syndrome.
Serrano-Mollar A; Fernández-Zabalegui L; Bulbena O; Gelpí E; Closa D
Chem Biol Interact; 2004 Oct; 149(2-3):117-23. PubMed ID: 15501433
[TBL] [Abstract][Full Text] [Related]
2. Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome.
Closa D; Folch E; Calaf RE; Abián J; Roselló-Catafau J; Gelpí E
Lipids; 2001 Oct; 36(10):1125-33. PubMed ID: 11768157
[TBL] [Abstract][Full Text] [Related]
3. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
[TBL] [Abstract][Full Text] [Related]
4. On the generation and outcome of 3-(N-phenylamino)propane-1,2-diol derivatives in deodorized model oils related to toxic oil syndrome.
Morató A; Escabrós J; Manich A; Reig N; Castaño Y; Abián J; Messeguer A
Chem Res Toxicol; 2005 Apr; 18(4):665-74. PubMed ID: 15833026
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man.
Carthew P; Edwards RE; Dorman BM; Verschoyle RD
Hum Exp Toxicol; 1995 Feb; 14(2):217-20. PubMed ID: 7779449
[TBL] [Abstract][Full Text] [Related]
7. Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils.
Ruiz-Méndez MV; Posada de la Paz M; Abian J; Calaf RE; Blount B; Castro-Molero N; Philen R; Gelpí E
Food Chem Toxicol; 2001 Jan; 39(1):91-6. PubMed ID: 11259855
[TBL] [Abstract][Full Text] [Related]
8. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
Schurz HH; Hill RH; Posada de la Paz M; Philen RM; Borda IA; Bailey SL; Needham LL
Chem Res Toxicol; 1996 Sep; 9(6):1001-6. PubMed ID: 8870988
[TBL] [Abstract][Full Text] [Related]
9. Study of apoptosis in human lymphocytes by toxic substances implicated in toxic oil syndrome.
Gallardo S; Cárdaba B; del Pozo V; de Andrés B; Cortegano I; Jurado A; Tramón P; Palomino P; Lahoz C
Toxicology; 1997 Mar; 118(1):71-82. PubMed ID: 9074655
[TBL] [Abstract][Full Text] [Related]
10. Endocytosis and intracellular trafficking of fatty acid esters of phenylaminopropanediol, the putative etiologic agents of the toxic oil syndrome (TOS).
Gonzalez JB; Orth M; Schaefer M; Tauber R
Toxicol Lett; 2006 Jun; 163(3):206-12. PubMed ID: 16343824
[TBL] [Abstract][Full Text] [Related]
11. LC-MS ion maps for the characterization of aniline derivatives of fatty acids and triglycerides in laboratory-denatured rapeseed oil.
Reig N; Calaf RE; Messeguer A; Morató A; Escabros J; Gelpí E; Abian J
J Mass Spectrom; 2007 Apr; 42(4):527-41. PubMed ID: 17295417
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid anilides: in vivo formation and relevance to toxic oil syndrome.
Kaphalia BS; Khan MF; Ansari GA
J Biochem Mol Toxicol; 1999; 13(5):269-77. PubMed ID: 10402561
[TBL] [Abstract][Full Text] [Related]
13. Studies on toxic oil syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase.
Morató A; Martínez-Cabot A; Escabrós J; Bujons J; Messeguer A
Chem Res Toxicol; 2004 Jul; 17(7):889-95. PubMed ID: 15257613
[TBL] [Abstract][Full Text] [Related]
14. In vitro bioactivation of 3-(N-phenylamino)propane-1,2-diol by human and rat liver microsomes and recombinant P450 enzymes. Implications for toxic oil syndrome.
Martínez-Cabot A; Morató A; Commandeur JN; Vermeulen NP; Messeguer A
Chem Res Toxicol; 2007 Aug; 20(8):1218-24. PubMed ID: 17672514
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice.
Ladona MG; Bujons J; Messeguer A; Ampurdanés C; Morató A; Corbella J
Chem Res Toxicol; 1999 Dec; 12(12):1127-37. PubMed ID: 10604860
[TBL] [Abstract][Full Text] [Related]
16. Toxic oil syndrome: genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice.
Gallardo S; Cárdaba B; Posada M; del Pozo V; Messeguer A; David CS; Lahoz C
Toxicol Lett; 2005 Nov; 159(2):173-81. PubMed ID: 15979827
[TBL] [Abstract][Full Text] [Related]
17. The acute pathology of fatty acid anilides and linoleic diester of 3-phenylamino-1,2-propanediol in mice: possible implication as aetiologic agents for the toxic oil syndrome.
Bell SA; Sander C; Kuntze I; Chatelain R
Arch Toxicol; 1999 Nov; 73(8-9):493-5. PubMed ID: 10650923
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic absorption of 3-phenylamino-1,2-propanediol and its esters.
Ruiz-Gutiérrez V; Maestro-Durán R
Exp Toxicol Pathol; 1992 Mar; 44(1):29-33. PubMed ID: 1392513
[TBL] [Abstract][Full Text] [Related]
19. Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS).
Messeguer A
Chem Biol Interact; 2011 Jun; 192(1-2):136-41. PubMed ID: 20970410
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
